J. & J. Booster Worked for People Who Got Pfizer Shots in Study

A small study in Boston looked at mixing and matching with the third shot.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Johnson & Pfizer Inc BioNTech SE Source Type: news

Related Links:

As the fast-spreading variant has blanketed the country, known cases and hospitalizations have surged, and officials warn of tough weeks ahead.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Vaccination and Immunization Coronavirus Omicron Variant Coronavirus (2019-nCoV) Murthy, Vivek H Jha, Ashish (1970- ) Source Type: news
One reader ’s experience of the effects on family members of the conspiracy theories surrounding vaccinationsI read David Green ’sletter on anti-vaxxers (12 January) and empathised with theletter written in response (13 January). The week before Christmas my dad died of Covid. The intensive care consultant couldn ’t have been clearer that, in her opinion, if he had been vaccinated he would not have developed Covid pneumonia to the severity that he did.He died very frightened and asking his family to come and be with him, and we couldn ’t. The experience traumatised my sister so badly that she was ho...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus Vaccines and immunisation Health Infectious diseases Medical research Science Society Source Type: news
Pfizer says its recently approved Paxlovid drug has almost 90% success in preventing severe illness if taken soon after infectionThe recent decision by regulators to approve the antiviral agent Paxlovid for use in the UK adds a formidable new weapon to the arsenal of treatments for Covid-19. Pfizer says the drug has almost 90% success in preventing severe illness in vulnerable adults if taken soon after infection occurs. Paxlovid is one of a growing repertoire of antiviral medicines – which also includes Merck’s agent Molnurpiravir – that can be given to people who have contracted the disease. Crucially, ...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus Infectious diseases Medical research Microbiology Science World news Pfizer Pharmaceuticals industry Immunology Biochemistry and molecular biology Source Type: news
AbstractThe first case of coronavirus illness was discovered in Wuhan, China, in January 2020 and quickly spread worldwide within the next couple of months. The condition was initially only linked with respiratory disorders. After the evolution of various variants of the SARS-CoV-2, the critical impact of the virus spread to multiple organs and soon, neurological disorder manifestations started to appear in the infected patients. The review is focused on the manifestation of various neurological disorders linked with both the central nervous system and peripheral nervous system. Disorders such as cytokine release syndrome,...
Source: Neurological Sciences - Category: Neurology Source Type: research
ConclusionsThyrotoxicosis can occur after SARS-CoV-2 vaccination probably related to silent thyroiditis.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
They could face more staff shortages, and workers and facilities could feel caught between opposing state and federal policies.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Hospitals Nursing and Nurses Shortages Workplace Hazards and Violations Supreme Court (US) States (US) United States Politics and Government Source Type: news
Cases seem to be subsiding in states with high vaccination rates, but observers are reluctant to make firm predictionsIn February 2021, Dr Craig Spencer wrote in a Mediumpost that he was as “eager as anyone to see the end of this pandemic. Thankfully, that may be in sight”.“Covid cases and hospitalizations are dropping,” wrote Spencer, director of Global Health in Emergency Medicine at New York-Presbyterian/Columbia University Medical Center. “Vaccines are getting into arms. So, what happens next?”Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Omicron variant Coronavirus Science New York US news North Carolina Source Type: news
Here's how this reaction may be different from an immediate skin reaction.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news
The stunning Covid vaccines manufactured by Pfizer-BioNTech and Moderna drew upon long-buried discoveries made in the hopes of ending past epidemics.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Clinical Trials Coronavirus (2019-nCoV) Vaccination and Immunization National Institutes of Health MERS (Middle East Respiratory Syndrome) Acquired Immune Deficiency Syndrome Graham, Barney S (1953- ) Kariko, Katalin (1955- ) Fauci, Anthon Source Type: news
In COVID-19 clinical update #97, Daniel Griffin covers immunity after infection recognized by CDC, outcomes before and after Omicron, infectious viral load in Delta vs Omicron, PCR vs rapid antigen tests, booster interval shortened to 5 months, risk factors for severe outcomes in vaccinated, cross-reactive memory T cells, vaccine effectiveness vs MIS-C, and Rivaroxiban for […]
Source: virology blog - Category: Virology Authors: Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation Long Covid monoclonal antibody pandemic SARS-CoV-2 vaccine vaccine booster variant of concern viruses Source Type: blogs
More News: Coronavirus | COVID-19 | Health | Pfizer | Study | Vaccines